Skip to main content
. 2016 Feb 4;20(6):1024–1035. doi: 10.1111/jcmm.12787

Figure 5.

Figure 5

Cumulative overall survival curve is shown for HCC patients according to infiltration of polarized TAMs in different TNM stages. Kaplan–Meier survival estimates and log‐rank tests were used to analyse the prognostic significance of polarized TAMs in each subgroup. (A and E) Patients with early‐stage tumour (TNM stages I and II; BCLC stages A and B) according to CD11c expression (high versus low, P = 0.028; high versus low, P = 0.003); (B and F) patients with early‐stage tumour (TNM stages I and II; BCLC stages A and B) according to CD206 expression (high versus low, P = 0.908; high versus low, P = 0.004); (C and G) patients with advanced‐stage tumour (TNM stages III and IV; BCLC stages C and D) according to CD11c expression (high versus low, P = 0.003; high versus low, P = 0.002); (D and H) patients with advanced‐stage tumour (TNM stages III and IV; BCLC stages C and D) according to CD206 expression (high versus low, P = 0.002; high versus low, P = 0.401). Dotted line, low group; solid line, high group.